FDA To Address Industry Questions In Transparency Effort
This article was originally published in The Tan Sheet
Executive Summary
FDA has expanded its transparency initiative to cover an unanticipated area - explaining how the agency works to the industries it regulates
You may also be interested in...
FDA Transparency Has No Clear Path To Releasing Documents - Woodcock
The possible release of FDA's voluminous documents is one of the more challenging aspects - both in policies and resources - of the agency's effort to make its operations and decisions more open to the public, FDA's Janet Woodcock says
FDA Transparency Has No Clear Path To Releasing Documents - Woodcock
The possible release of FDA's voluminous documents is one of the more challenging aspects - both in policies and resources - of the agency's effort to make its operations and decisions more open to the public, FDA's Janet Woodcock says
FDA Transparency Has No Clear Path To Releasing Documents - Woodcock
The possible release of FDA's voluminous documents is one of the more challenging aspects - both in policies and resources - of the agency's effort to make its operations and decisions more open to the public, FDA's Janet Woodcock says